FDA has questions about Merck's experimental chronic cough drug
January 24, 2022 at 12:13 PM EST
The chronic cough drug was approved in Japan, where it will be marketed under the brand name Lyfnua.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
San Anselmo | San Anselmo News | San Anselmo Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|